PI3K alpha inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma
文献类型:期刊论文
作者 | Xie, Qin1,2; Chi, Shuaishuai1,3; Fang, Yanfen1; Sun, Yiming1; Meng, Linghua1; Ding, Jian1,4,5; Chen, Yi1,3 |
刊名 | SIGNAL TRANSDUCTION AND TARGETED THERAPY |
出版日期 | 2021-03-31 |
卷号 | 6期号:1页码:3 |
ISSN号 | 2095-9907 |
DOI | 10.1038/s41392-021-00522-6 |
通讯作者 | Ding, Jian(jding@simm.ac.cn) ; Chen, Yi(ychen@simm.ac.cn) |
资助项目 | Strategic Priority Research Program of the Chinese Academy of Science[XDA12020101] ; Strategic Priority Research Program of the Chinese Academy of Science[XDA12050101] ; National Natural Science Foundation of China[81521005] |
WOS研究方向 | Biochemistry & Molecular Biology ; Cell Biology |
语种 | 英语 |
出版者 | SPRINGERNATURE |
WOS记录号 | WOS:000636231100001 |
源URL | [http://119.78.100.183/handle/2S10ELR8/295443] |
专题 | 新药研究国家重点实验室 |
通讯作者 | Ding, Jian; Chen, Yi |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai, Peoples R China 2.Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou, Peoples R China 3.Univ Chinese Acad Sci, Beijing, Peoples R China 4.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China 5.Shanghai HaiHe Pharmaceut Co Ltd, Shanghai, Peoples R China |
推荐引用方式 GB/T 7714 | Xie, Qin,Chi, Shuaishuai,Fang, Yanfen,et al. PI3K alpha inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma[J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY,2021,6(1):3. |
APA | Xie, Qin.,Chi, Shuaishuai.,Fang, Yanfen.,Sun, Yiming.,Meng, Linghua.,...&Chen, Yi.(2021).PI3K alpha inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma.SIGNAL TRANSDUCTION AND TARGETED THERAPY,6(1),3. |
MLA | Xie, Qin,et al."PI3K alpha inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma".SIGNAL TRANSDUCTION AND TARGETED THERAPY 6.1(2021):3. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。